BNP Paribas Financial Markets’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $52.9M | Buy |
185,544
+1,188
| +0.6% | +$350K | 0.02% | 736 |
|
|
2026
Q1 | $54.7M | Sell |
184,356
-9,595
| -5% | -$3.11M | 0.03% | 638 |
|
|
2025
Q4 | $58.9M | Buy |
193,951
+97,244
| +101% | +$31.8M | 0.03% | 607 |
|
|
2025
Q3 | $32.9M | Sell |
96,707
-61,665
| -39% | -$18.7M | 0.02% | 826 |
|
|
2025
Q2 | $38.3M | Sell |
158,372
-13,508
| -8% | -$3.31M | 0.02% | 703 |
|
|
2025
Q1 | $46.8M | Buy |
171,880
+68,817
| +67% | +$16.1M | 0.03% | 627 |
|
|
2024
Q4 | $19M | Buy |
103,063
+97,783
| +1,852% | +$20M | 0.01% | 1044 |
|
|
2024
Q3 | $1.19M | Sell |
5,280
-573
| -10% | -$103K | ﹤0.01% | 2394 |
|
|
2024
Q2 | $835K | Sell |
5,853
-1,589
| -21% | -$245K | ﹤0.01% | 2383 |
|
|
2024
Q1 | $1.16M | Sell |
7,442
-51,865
| -87% | -$8.35M | ﹤0.01% | 2396 |
|
|
2023
Q4 | $10.7M | Buy |
59,307
+58,549
| +7,724% | +$10.6M | 0.01% | 995 |
|
|
2023
Q3 | $136K | Sell |
758
-385
| -34% | -$76.2K | ﹤0.01% | 3236 |
|
|
2023
Q2 | $204K | Sell |
1,143
-469
| -29% | -$108K | ﹤0.01% | 3010 |
|
|
2023
Q1 | $347K | Buy |
1,612
+956
| +146% | +$229K | ﹤0.01% | 2913 |
|
|
2022
Q4 | $144K | Sell |
656
-71,390
| -99% | -$13.1M | ﹤0.01% | 3116 |
|
|
2022
Q3 | $9.71M | Buy |
72,046
+8,853
| +14% | +$1.52M | 0.02% | 991 |
|
|
2022
Q2 | $10.2M | Sell |
63,193
-10,780
| -15% | -$1.68M | 0.02% | 877 |
|
|
2022
Q1 | $14M | Sell |
73,973
-15,034
| -17% | -$3.2M | 0.02% | 759 |
|
|
2021
Q4 | $24.1M | Buy |
89,007
+9,493
| +12% | +$3.21M | 0.03% | 570 |
|
|
2021
Q3 | $28.9M | Sell |
79,514
-1,704
| -2% | -$557K | 0.04% | 462 |
|
|
2021
Q2 | $27.9M | Buy |
81,218
+4,906
| +6% | +$1.63M | 0.04% | 505 |
|
|
2021
Q1 | $26.6M | Buy |
76,312
+20,277
| +36% | +$6.71M | 0.04% | 452 |
|
|
2020
Q4 | $14.5M | Buy |
56,035
+42,458
| +313% | +$11.7M | 0.03% | 626 |
|
|
2020
Q3 | $3.89M | Buy |
13,577
+1,874
| +16% | +$440K | 0.01% | 1214 |
|
|
2020
Q2 | $2.2M | Sell |
11,703
-16,429
| -58% | -$2.67M | ﹤0.01% | 1455 |
|
|
2020
Q1 | $3.46M | Buy |
28,132
+19,005
| +208% | +$2.97M | 0.01% | 1170 |
|
|
2019
Q4 | $1.51M | Sell |
9,127
-5,327
| -37% | -$885K | ﹤0.01% | 1821 |
|
|
2019
Q3 | $1.77M | Sell |
14,454
-3,547
| -20% | -$471K | ﹤0.01% | 1576 |
|
|
2019
Q2 | $2.23M | Buy |
18,001
+6,235
| +53% | +$791K | ﹤0.01% | 1407 |
|
|
2019
Q1 | $1.55M | Sell |
11,766
-3,793
| -24% | -$512K | ﹤0.01% | 1512 |
|
|
2018
Q4 | $2.18M | Sell |
15,559
-3,778
| -20% | -$501K | 0.01% | 1278 |
|
|
2018
Q3 | $3.33M | Buy |
19,337
+16,970
| +717% | +$2.85M | ﹤0.01% | 1304 |
|
|
2018
Q2 | $364K | Buy |
2,367
+1,859
| +366% | +$332K | ﹤0.01% | 2151 |
|
|
2018
Q1 | $85.3K | Buy |
+508
| New | +$68.8K | ﹤0.01% | 3271 |
|
Other funds holding ONC
BBA
BNP Paribas Financial Markets's ONC Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its BeOne Medicines Ltd (ONC) stake by 0.64% in Q2 2026, buying an estimated $350K and bringing the position to 185,544 shares worth $52.9M. The position accounts for 0.02% of the portfolio, ranked #736.
BNP Paribas Financial Markets first reported a position in ONC in Q1 2018 and has held it in 34 quarters since. The position peaked at $58.9M in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.
- BNP Paribas Financial Markets held 185,544 shares of BeOne Medicines Ltd worth $52.9M as of Q2 2026.
- BNP Paribas Financial Markets bought 1,188 BeOne Medicines Ltd shares in Q2 2026, an estimated $350K.
- BeOne Medicines Ltd made up 0.02% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #736 holding.
- BNP Paribas Financial Markets first reported a position in BeOne Medicines Ltd in Q1 2018 and has held it in 34 quarters since.
- BNP Paribas Financial Markets's BeOne Medicines Ltd position peaked at $58.9M in Q4 2025.
- 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.